New strategies for confirmatory testing of secondary hypotheses on combined data from multiple trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 171, doi. 10.1177/17407745231214382
- By:
- Publication type:
- Article
Works matching IS 17407745 AND DT 2024 AND VI 21 AND IP 2
Results: 14
1
2
Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 211, doi. 10.1177/17407745231210872
- By:
- Publication type:
- Article
3
Adherence to key recommendations for design and analysis of stepped-wedge cluster randomized trials: A review of trials published 2016–2022.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 199, doi. 10.1177/17407745231208397
- By:
- Publication type:
- Article
4
Industry payments and brand-name tyrosine kinase inhibitor use amid generic entry.
- Published in:
- 2024
- By:
- Publication type:
- Letter
5
Algorithmic benchmark modulation: A novel method to develop success rates for clinical studies.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 220, doi. 10.1177/17407745231207858
- By:
- Publication type:
- Article
6
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 180, doi. 10.1177/17407745231206465
- By:
- Publication type:
- Article
7
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 189, doi. 10.1177/17407745231206402
- By:
- Publication type:
- Article
8
Unresolved issues with noninferiority pragmatic trials: Results of a literature survey.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 242, doi. 10.1177/17407745231206371
- By:
- Publication type:
- Article
9
Do recruitment SWAT interventions have an impact on participant retention in randomised controlled trials? A systematic review.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 233, doi. 10.1177/17407745231206283
- By:
- Publication type:
- Article
10
When should factorial designs be used for late-phase randomised controlled trials?
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 162, doi. 10.1177/17407745231206261
- By:
- Publication type:
- Article
11
A critique on "A randomized evaluation of on-site monitoring nested in a multinational randomized trial".
- Published in:
- 2024
- By:
- Publication type:
- Letter
12
Shedding light on data monitoring committee charters on ClinicalTrials.gov.
- Published in:
- 2024
- By:
- Publication type:
- Letter
13
Statistical rules for safety monitoring in clinical trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 152, doi. 10.1177/17407745231203391
- By:
- Publication type:
- Article
14
The impact of feedback training on prediction of cancer clinical trial results.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 143, doi. 10.1177/17407745231203375
- By:
- Publication type:
- Article